Validation pour Ingenuity256

vers la météo de la validation par utilisateur

Ingenuity256

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 66 - PMID ?

In liver from SP , 17 alpha ethinylestradiol causes little or no change in expression of SP NODE mRNA that involves transgenic SP NODE protein and transgenic NODE protein .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

      +---------------------------------------COMP:V-N(In)---------------------------------------+                                                                                                   
      |           +--------------------------------COMP:V-N(from)--------------------------------+                          +------------------------------OBJ:V-N-----------------------------+     
      |           |      +--------------------------------SUBJ:V-N-------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |           |      |                           +----------COMP:V-N(in)---------+           |                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+------OBJ:V-N------+           |           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+OBJ:V-+            |           +MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
COMP:V-N(from) (__SP__,__SP__)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 1

      +---------------------------------------COMP:V-N(In)---------------------------------------+                          +------------------------------OBJ:V-N-----------------------------+     
      |                  +--------------------------------SUBJ:V-N-------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |                  |                           +----------COMP:V-N(in)---------+           |                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+------OBJ:V-N------+           |           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+OBJ:V-+            |           +MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 2

      +---------------------------------------COMP:V-N(In)---------------------------------------+-------------------------------------------OBJ:V-N-------------------------------------------+     
      |                  +--------------------------------SUBJ:V-N-------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |                  |                           +----------COMP:V-N(in)---------+           |                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+------OBJ:V-N------+           |           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+OBJ:V-+            |           +MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 3

      +---------------------------------------COMP:V-N(In)---------------------------------------+                          +------------------------------OBJ:V-N-----------------------------+     
      |           +--------------------------------COMP:V-N(from)--------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |           |      +--------------------------------SUBJ:V-N-------------------------------+                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                                           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+------OBJ:V-N------+COMP:N-N(in+MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |                   |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
COMP:V-N(from) (__SP__,__SP__)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 4

      +---------------------------------------COMP:V-N(In)---------------------------------------+                          +------------------------------OBJ:V-N-----------------------------+     
      |           +--------------------------------COMP:V-N(from)--------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |           |      +--------------------------------SUBJ:V-N-------------------------------+                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +--MOD_POST:N-ADJ--+    +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+------OBJ:V-N------+COMP:N-N(in+      |    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |                   |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (change,of)
COMP:V-N(In) (__SP__,liver)
COMP:V-N(from) (__SP__,__SP__)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 5

      +---------------------------------------COMP:V-N(In)---------------------------------------+                                                                                                   
      |           +--------------------------------COMP:V-N(from)--------------------------------+                          +------------------------------OBJ:V-N-----------------------------+     
      |           |      +--------------------------------SUBJ:V-N-------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |           |      |                                  +------COMP:N-N(in)------+           |                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+------OBJ:V-N------+           |           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+OBJ:V-+            +COMP:N-N(in+MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
COMP:V-N(from) (__SP__,__SP__)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 6

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 7

      +---------------------------------------COMP:V-N(In)---------------------------------------+                                                                                                   
      |                  +--------------------------------SUBJ:V-N-------------------------------+                          +------------------------------OBJ:V-N-----------------------------+     
      |                  |                                  +---------MOD_POST:N-ADJ--------+    |                          +--------------OBJ:V-N-------------+                               |     
      |                  |                                  +------COMP:N-N(in)------+      |    |                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+------OBJ:V-N------+--MOD_POST:N-ADJ--+    +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+OBJ:V-+            +COMP:N-N(in+      |    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
MOD_POST:N-ADJ (little,of)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (change,of)
COMP:V-N(In) (__SP__,liver)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 8

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |           +------------------------------------COMP:V-N(from)------------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |           |      +------------------------------------SUBJ:V-N-----------------------------------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 9

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                                           
      |           +------------------------------------COMP:V-N(from)------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |           |      +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |           |      |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 10

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+                                      +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 11

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+                                      +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 12

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               +-------------COMP:N-N(of)-------------+                                      +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 13

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               +-------------COMP:N-N(of)-------------+                                      +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 14

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |           |      |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 15

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 16

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |           |      |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 17

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 18

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |           |      |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 19

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 20

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |           |      |                                               +-------------COMP:N-N(of)-------------+           |                          +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 21

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |                  |                                               +-------------COMP:N-N(of)-------------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 22

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |           +------------------------------------COMP:V-N(from)------------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |           |      +------------------------------------SUBJ:V-N-----------------------------------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 23

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 24

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                                           
      |           +------------------------------------COMP:V-N(from)------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |           |      +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |           |      |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 25

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 26

                                                                                                         +---------------------------------------OBJ:V-N---------------------------------------+     
      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 27

      +---------------------------------------COMP:V-N(In)---------------------------------------+-------------------------------------------OBJ:V-N-------------------------------------------+     
      |           +--------------------------------COMP:V-N(from)--------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |           |      +--------------------------------SUBJ:V-N-------------------------------+                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                                           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+------OBJ:V-N------+COMP:N-N(in+MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |                   |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
COMP:V-N(from) (__SP__,__SP__)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 28

                                                                                                 +-------------------------------------------OBJ:V-N-------------------------------------------+     
      +---------------------------------------COMP:V-N(In)---------------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |                  +--------------------------------SUBJ:V-N-------------------------------+                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                                           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+------OBJ:V-N------+COMP:N-N(in+MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |                   |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 29

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+---------------------------------------OBJ:V-N---------------------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 30

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+---------------------------------------OBJ:V-N---------------------------------------+     
      |           +------------------------------------COMP:V-N(from)------------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |           |      +------------------------------------SUBJ:V-N-----------------------------------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 31

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                                           
      |           +------------------------------------COMP:V-N(from)------------------------------------+---------------------------------------OBJ:V-N---------------------------------------+     
      |           |      +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |           |      |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 32

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
      +--------------------------COMP:N-N(from)--------------------------+           +-------COMP:N-N(of)-------+           |         +------MOD_ATT:N-ADJ-----+                               |     
      +--COMP:N-N(from)--+----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            |           |           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(from) (liver,@card@)
COMP:N-N(from) (liver,change)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 33

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
      +-----------------------------------------------COMP:N-N(of)----------------------------------------------+           +--------------OBJ:V-N-------------+                               |     
      +--------------------------COMP:N-N(from)--------------------------+                                      |           |         +------MOD_ATT:N-ADJ-----+                               |     
      +--COMP:N-N(from)--+----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(from) (liver,@card@)
COMP:N-N(from) (liver,change)
COMP:N-N(of) (liver,mRNA)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 34

      +---------------------------------------COMP:V-N(In)---------------------------------------+-------------------------------------------OBJ:V-N-------------------------------------------+     
      |                  +--------------------------------SUBJ:V-N-------------------------------+                          +--------------OBJ:V-N-------------+                               |     
      |                  |                                  +------COMP:N-N(in)------+           |                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+------OBJ:V-N------+           |           +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+OBJ:V-+            +COMP:N-N(in+MOD_PO+    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (expression,of)
COMP:V-N(In) (__SP__,liver)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 35

      +---------------------------------------COMP:V-N(In)---------------------------------------+                                                                                                   
      |                  +--------------------------------SUBJ:V-N-------------------------------+-------------------------------------------OBJ:V-N-------------------------------------------+     
      |                  |                                  +---------MOD_POST:N-ADJ--------+    |                          +--------------OBJ:V-N-------------+                               |     
      |                  |                                  +------COMP:N-N(in)------+      |    |                          |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+------OBJ:V-N------+--MOD_POST:N-ADJ--+    +----OBJ:V-N---+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+OBJ:V-+            +COMP:N-N(in+      |    |       +MOD_AT+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |      |    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
MOD_POST:N-ADJ (little,of)
COMP:N-N(in) (change,expression)
MOD_POST:N-ADJ (change,of)
COMP:V-N(In) (__SP__,liver)
SUBJ:V-N (__SP__,@card@)
OBJ:V-N (__SP__,mRNA)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 36

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
                                                                         +-------------COMP:N-N(of)-------------+           |         +------MOD_ATT:N-ADJ-----+                               |     
                         +----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 37

                                                                                                         +---------------------------------------OBJ:V-N---------------------------------------+     
      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 38

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+---------------------------------------OBJ:V-N---------------------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 39

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
      +--------------------------COMP:N-N(from)--------------------------+           +-------COMP:N-N(of)-------+           |         +------MOD_ATT:N-ADJ-----+                               |     
      +--COMP:N-N(from)--+----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(from) (liver,@card@)
COMP:N-N(from) (liver,change)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 40

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
                                                                                     +-------COMP:N-N(of)-------+           |         +------MOD_ATT:N-ADJ-----+                               |     
                         +----------OBJ:V-N----------+                               |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
                         |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
                         |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 41

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
                                                                         +-------------COMP:N-N(of)-------------+           |         +------MOD_ATT:N-ADJ-----+                               |     
                         +----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
                         |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
                         |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 42

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+                                      +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 43

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 44

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |                  |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 45

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |                  |                                               +-------------COMP:N-N(of)-------------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 46

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |           |      |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 47

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      |                                               +---------------------SUBJ:V-N---------------------+                          |                                             
      |           |      |                                               |           +-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,change)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 48

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
                                                                                                                            |         +------MOD_ATT:N-ADJ-----+                               |     
                         +----------OBJ:V-N----------+                                           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 49

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------COMP:N-N(in)-----------------------+                   |                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 50

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------COMP:N-N(in)-----------------------+                   |                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 51

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                                           
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                                                                                           
      |                  +------------------------------COMP:N-N(of)-----------------------------+       |                  +------------------------------OBJ:V-N-----------------------------+     
      |                  +------------------------COMP:N-N(in)-----------------------+           |       |                  +--------------OBJ:V-N-------------+                               |     
      |                  |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
COMP:N-N(of) (@card@,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 52

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
                                                                                                                            |         +------MOD_ATT:N-ADJ-----+                               |     
                         +----------OBJ:V-N----------+                                           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+                                    |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |                                    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 53

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+                                      +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 54

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+                                      +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 55

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |                  +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 56

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |                  +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 57

      +--------------------------COMP:N-N(from)--------------------------+                                                  +------------------------------OBJ:V-N-----------------------------+     
      |           +---------------------------COMP:N-N(in)---------------------------+                                      +--------------OBJ:V-N-------------+                               |     
      |           |      +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+           |         +------MOD_ATT:N-ADJ-----+                               |     
      +--COMP:N-N(from)--+----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(from) (liver,@card@)
COMP:N-N(from) (liver,change)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 58

                  +-----------------------------------------COMP:N-N(of)----------------------------------------+                                                                                    
                  |      +-------------------------------------COMP:N-N(of)-------------------------------------+                                                                                    
      +--------------------------COMP:N-N(from)--------------------------+                                      |                                                                                    
      |           +---------------------------COMP:N-N(in)---------------------------+                          |           +------------------------------OBJ:V-N-----------------------------+     
      |           |      +------------------------COMP:N-N(in)-----------------------+                          |           +--------------OBJ:V-N-------------+                               |     
      |           |      |                                               +-------------COMP:N-N(of)-------------+           |         +------MOD_ATT:N-ADJ-----+                               |     
      +--COMP:N-N(from)--+----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(from) (liver,@card@)
COMP:N-N(from) (liver,change)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(of) (__SP__,mRNA)
COMP:N-N(in) (@card@,expression)
COMP:N-N(of) (@card@,mRNA)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 59

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
      +--------------------------COMP:N-N(from)--------------------------+                                                  |         +------MOD_ATT:N-ADJ-----+                               |     
      +--COMP:N-N(from)--+----------OBJ:V-N----------+                   |                       +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            |                       |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |                       |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(from) (liver,@card@)
COMP:N-N(from) (liver,change)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 60

      +-----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                                    
      +--------------------------COMP:N-N(from)--------------------------+                                      |           +------------------------------OBJ:V-N-----------------------------+     
      |           +---------------------------COMP:N-N(in)---------------------------+                          |           +--------------OBJ:V-N-------------+                               |     
      |           |      +------------------------COMP:N-N(in)-----------------------+                          |           |         +------MOD_ATT:N-ADJ-----+                               |     
      +--COMP:N-N(from)--+----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(from) (liver,@card@)
COMP:N-N(from) (liver,change)
COMP:N-N(of) (liver,mRNA)
COMP:N-N(in) (__SP__,expression)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 61

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                  +---------------------------COMP:N-N(in)---------------------------+                                      +--------------OBJ:V-N-------------+                               |     
                  |      +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+           |         +------MOD_ATT:N-ADJ-----+                               |     
                  |      +----------OBJ:V-N----------+                               |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
                  |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
                  |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(in) (__SP__,expression)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 62

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                                                                                                                            +--------------OBJ:V-N-------------+                               |     
                                                                                                                            |         +------MOD_ATT:N-ADJ-----+                               |     
                         +----------OBJ:V-N----------+                                           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
                         |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+                                    |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
                         |   |           |           |      |                                    |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 63

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+---------------------------------------OBJ:V-N---------------------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------COMP:N-N(in)-----------------------+                   |                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 64

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                  +------------------------------OBJ:V-N-----------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------COMP:N-N(in)-----------------------+                   |                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 65

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                                           
      |           +------------------------------------COMP:V-N(from)------------------------------------+                                                                                           
      |           |      +------------------------------------SUBJ:V-N-----------------------------------+                                                                                           
      |           |      +------------------------------COMP:N-N(of)-----------------------------+       |                  +------------------------------OBJ:V-N-----------------------------+     
      |           |      +------------------------COMP:N-N(in)-----------------------+           |       |                  +--------------OBJ:V-N-------------+                               |     
      |           |      |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |           |      +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(in) (@card@,expression)
COMP:N-N(of) (@card@,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 66

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                                           
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                                                                                           
      |                  +------------------------------COMP:N-N(of)-----------------------------+       |                  +------------------------------OBJ:V-N-----------------------------+     
      |                  +------------------------COMP:N-N(in)-----------------------+           |       |                  +--------------OBJ:V-N-------------+                               |     
      |                  |                                               +------------SUBJ:V-N-----------+                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------COMP:N-N(of)-----+       |                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
COMP:N-N(of) (@card@,__SP__)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 67

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+                                      +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 68

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+                                      +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+--SUBJ:V-N-+         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 69

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |                  +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |                  |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |                  |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |                  +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |                  +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 70

      +------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------+                                             
      |           +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                             
      |           |      +-----------------------------------------------------------SUBJ:V-N----------------------------------------------------------+                                             
      |           |      |                                               +-----------------------------------SUBJ:V-N----------------------------------+                                             
      |           |      |                                               |           +---------------SUBJ:V-N---------------+                          |                                             
      |           |      +------------------------COMP:N-N(in)-----------------------+-------COMP:N-N(of)-------+           |                          +----------------OBJ:V-N----------------+     
      |           |      +----------OBJ:V-N----------+                   |           |           +-MOD_ATT:N-ADJ+           +------OBJ:V-N-----+       |                     +--MOD_ATT:N-ADJ--+     
      |           |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         +MOD_ATT:+       +OBJ:V-N+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__SP__)
MOD_ATT:N-ADJ (__SP__,transgenic)
COMP:V-N(In) (__NODE__,liver)
COMP:V-N(from) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,protein)
OBJ:V-N (__NODE__,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 71

      +-------------------------------------------COMP:V-N(In)-------------------------------------------+---------------------------------------OBJ:V-N---------------------------------------+     
      |                  +------------------------------------SUBJ:V-N-----------------------------------+                  +--------------OBJ:V-N-------------+                               |     
      |                  +------------------------COMP:N-N(in)-----------------------+                   |                  |         +------MOD_ATT:N-ADJ-----+                               |     
      |                  +----------OBJ:V-N----------+                   +------------SUBJ:V-N-----------+                  |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
      +COMP:N-N(fr+      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+--SUBJ:V-N-+         |        |       +MOD_ATT+             |         +MOD_ATT+     
      |           |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,liver)
SUBJ:V-N (__NODE__,@card@)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)
OBJ:V-N (__NODE__,protein)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 72

                                                                                                                            +------------------------------OBJ:V-N-----------------------------+     
                  +---------------------------COMP:N-N(in)---------------------------+                                      +--------------OBJ:V-N-------------+                               |     
                  |      +------------------------COMP:N-N(in)-----------------------+                                      |         +------MOD_ATT:N-ADJ-----+                               |     
                  |      +----------OBJ:V-N----------+                               |           +-MOD_ATT:N-ADJ+           |         |        +-MOD_ATT:N-ADJ-+             +--MOD_ATT:N-ADJ--+     
                  |      |   +MOD_ATT:N-N+--SUBJ:V-N-+MOD:V-+            +COMP:N-N(in+           |       +MOD_AT+           |         |        |       +MOD_ATT+             |         +MOD_ATT+     
                  |      |   |           |           |      |            |           |           |       |      |           |         |        |       |       |             |         |       |     
 In liver from __SP__ , 17 alpha ethinylestradiol causes little or no change in expression of __SP__ __NODE__ mRNA that involves transgenic __SP__ __NODE__ protein and transgenic __NODE__ protein .
COMP:N-N(in) (__SP__,expression)
COMP:N-N(in) (@card@,expression)
MOD_ATT:N-N (ethinylestradiol,alpha)
OBJ:V-N (cause,@card@)
SUBJ:V-N (cause,ethinylestradiol)
MOD:V-ADV (cause,little)
COMP:N-N(in) (change,expression)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (involve,protein)
OBJ:V-N (involve,protein)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,transgenic)
MOD_ATT:N-ADJ (protein,__NODE__)